Left ventricular quantification with breath-hold MR imaging: comparison with echocardiography.

To evaluate the reproducibility of measurements of left ventricular (LV) dimensions, function, and myocardial mass, segmented k-space gradient-recalled-echo (GRE) magnetic resonance (MR) imaging was performed on two occasions on 12 healthy volunteers. To compare the MR data, all volunteers underwent a two-dimensional echocardiography with determination of LV dimensions and function. The left ventricle was imaged during breath-hold by consecutive, contiguous short-axis views at end-diastole and end-systole. An average of eight short-axis views was needed to encompass the whole left ventricle. This fast MR sequence limited the total acquisition time to 12 min. LV volumes and masses were calculated after manual delineation of epicardial and endocardial surfaces by two observers in a blinded fashion. Interstudy variability varied between 4.1% and 10.3% for LV end-diastolic volume and end-systolic volume, respectively. Differences in interobserver variability were smaller and varied between 3.6% and 7.3% for LV ejection fraction and end-diastolic volume, respectively. Intraobserver variabilities ranged between 2.0% and 7.0% for LV ejection fraction and end-systolic volume, respectively. These variability percentages agree very well with other studies in literature using other MR sequences. No significant differences in LV dimensions or function were found between MR imaging and echocardiography. In conclusion, this MR sequence allows fast and reproducible LV quantification.

Determination of left ventricular volume by two-dimensional echocardiography: comparison with magnetic resonance imaging.

Left ventricular volume was determined in 12 healthy volunteers using a newly developed two-dimensional echocardiographic delineation method. The results were compared with those of magnetic resonance imaging, which served as the method of reference. Left ventricular end-diastolic volume was 123 +/- 12 ml, echocardiographically defined, and 121 +/- 12 ml calculated with magnetic resonance imaging. End-systolic volume was 41 +/- 7 ml on echocardiography and 37 +/- 6 ml on magnetic resonance imaging. Left ventricular ejection fraction was 67 +/- 4%, echocardiographically defined, and 70 +/- 5%, calculated with magnetic resonance imaging. There was no statistical difference for any of the measured parameters. Interstudy and inter-observer variability was minimal. In conclusion, in healthy volunteers left ventricular volume was accurately defined, using this newly developed two-dimensional echocardiographic delineation method. During endocardial delineation a dynamic display is continuously available on a second window, allowing precise visual edge-detection. Moreover, corrections can be made easily and quickly. These two advantages enhance the accuracy of the method, even in cases of poor echogenicity.

FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.

Exact localisation of thoracic lymph nodes (LNs) on fluorine-18 fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) can be hampered by the paucity of anatomical landmarks. In non-small cell lung cancer (NSCLC) patients referred for locoregional LN staging, we prospectively examined to what extent localisation of LNs at PET reading could be improved by visual correlation with computed tomography (CT), or by anatometabolic PET+CT fusion images. Fifty-six patients with potentially operable NSCLC underwent CT, PET and surgical staging. Prospective reading was performed for CT, PET without CT, PET+CT visual correlation and PET+CT fusion. Reading was blinded to surgical pathology data and noted on a standard LN map. Surgical staging was available for 493 LN stations. In the evaluation per individual LN station, CT was accurate in 87%, PET in 91% and visual correlation and fusion in 93%. In the identification of the nodal stage, CT was correct in 28/56 patients (50%), PET in 37/56 (66%), visual correlation in 40/56 (71%), and fusion in 41/56 (73%). It is concluded that in the exact localisation of metastatic thoracic LNs, the accuracy of reading of PET is increased if the PET images can be visually correlated with CT images. PET+CT anatometabolic fusion images add only a marginal benefit compared with visual correlation.